Cargando…
Validation of a Liquid Chromatography-Tandem Mass Spectrometric Assay for Quantitative Analysis of Lenvatinib in Human Plasma
Toward conducting clinical pharmacokinetic studies of an antineoplastic agent, lenvatinib, we developed a liquid chromatography-tandem mass spectrometric assay for its quantitative analysis in human plasma. Analyte (lenvatinib) and internal standard (IS, propranolol) in the plasma were extracted by...
Autores principales: | Ogawa-Morita, Tomoko, Sano, Yoshiyuki, Okano, Tomoka, Fujii, Hirofumi, Tahara, Makoto, Yamaguchi, Masakazu, Minami, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478828/ https://www.ncbi.nlm.nih.gov/pubmed/28680445 http://dx.doi.org/10.1155/2017/2341876 |
Ejemplares similares
-
Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017) -
A rapid and sensitive liquid chromatography–tandem mass spectrometric assay for duloxetine in human plasma: Its pharmacokinetic application
por: Gajula, Ramakrishna, et al.
Publicado: (2013) -
Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
por: Zayed, Aref, et al.
Publicado: (2018) -
Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2019) -
Impact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
por: Shibutani, Yuma, et al.
Publicado: (2023)